Officiële publicaties Genmab A/S Deutsche Boerse AG

Aandelen

Geschatte realtime Tradegate Andere beurzen 19:24:43 01-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
231,6 ^EUR	-0,49%		-1,93%	-18,86%

28/06	Lymfoomtherapie van Genmab en AbbVie aanbevolen voor goedkeuring in EU	MT
28/06	AbbVie, Genmab ontvangen positief Europees advies over marktvergunning voor mogelijke behandeling van lymfklierkanker	MT

Acquisition	21/05	CO
Share buyback	06/05	CO
1st quarter results	02/05	CO
Share buyback	22/04	CO
Share buyback	15/04	CO
Share buyback	08/04	CO
Share buyback	02/04	CO
Share buyback	25/03	CO
Minutes of the general assembly	13/03	CO
Share buyback	11/03	CO
Share buyback	04/03	CO
Mixed general shareholder meeting	15/02	CO
Share buyback	14/02	CO
Annual ESG Report	14/02	CO
Annual Report	14/02	CO
Annual Report	14/02	CO
3rd quarter results	07/11	CO
Admission of new securities	15-08-23	CO
1st-half-year results	03-08-23	CO
1st quarter results	10-05-23	CO
Shareholders meeting voting results	29-03-23	CO
Changes in management and corporate officers	28-03-23	CO
Share buyback	27-03-23	CO
Share buyback	20-03-23	CO
Share buyback	13-03-23	CO